Introduction This chapter reviews the nonpharmaceutical interventions for the treatment of osteosarcopenia in older adults. Modifiable risk factors such as exercise, nutrition, nutritional supplements, supplements plus nutrition, and complex interventions…
It is well-documented that “…the conditions in which people are born, grow, work, live, and age…” can negatively, or positively, influence our health. With few exceptions, an inverse association is…
Diagnosis of osteosarcopenia—Quantitative imaging Introduction The prevalence, importance, and impact of osteosarcopenia and its constituent syndromes (osteoporosis and sarcopenia) have been covered in previous chapters. Here, we briefly focus on…
Introduction Osteosarcopenia (OSP) is a geriatric syndrome characterized by systemic loss of bone (osteopenia/osteoporosis), muscle strength, and muscle mass (sarcopenia) . The age-related loss of bone and muscle tissues is…
Overview Osteosarcopenia is an age-related syndrome characterized by a low mass of the musculoskeletal unit composed of muscles and bones . Osteosarcopenia was first described in 2009 as the coexistence…
Introduction Sex steroids are fundamentally important to human sexual differentiation and maturation. Given the anatomical differences evident between the human male and female phenotype, it is thus no surprise that…
What is osteosarcopenic adiposity/obesity and what is in its name? Introduction Osteosarcopenic adiposity/obesity (OSA/OSO) was officially identified in 2014, when a theoretical concept supported by scientific evidence and research findings,…
Introduction Osteosarcopenia is the combined diagnosis of both osteoporosis and sarcopenia, both of which are conditions associated with aging . Sarcopenia is currently defined by the European Working Group on…
Introduction Modern medicine has managed to increase human lifespan by finding better treatments for diseases that at one time were incurable. Diseases like smallpox, carried by the variola virus, killed…
Acknowledgment This work was supported, in part, by grants from National Institutes of Health (NIH), United States (R01 AI108907, R42AG054322, U54 AG062333, and R21 AG059742), and funding from Irma and…
